Gao Junli

A Boston-based investment group that provides seed funding to early-stage life science and healthcare companies.The Sky Ventures Group brings diverse classes of prestigious investors together including top-tier corporate venture capital, foundations, family offices and individual angel investors who want to change the early stage investment landscape and impact lives by building outstanding life science & healthcare companies.

Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Our goal is to provide money and mentoring to the life science community to achieve superior returns for our group, and more clinical innovation for the community. Our focus is on early stage life science companies looking to raise $250K to $3.0M. Depending on the amount of funding needed, we can fund all or a portion of the round, and will work closely with other angel groups or venture funds in the area to complete the round. We are looking for companies that are extremely capital efficient opportunities where our funds will lead to significant step-ups in valuation to avoid unfavorable future funding rounds.

A Boston-based investment group that provides seed funding to early-stage life science and healthcare companies.The Sky Ventures Group brings diverse classes of prestigious investors together including top-tier corporate venture capital, foundations, family offices and individual angel investors who want to change the early stage investment landscape and impact lives by building outstanding life science & healthcare companies.

Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Our goal is to provide money and mentoring to the life science community to achieve superior returns for our group, and more clinical innovation for the community. Our focus is on early stage life science companies looking to raise $250K to $3.0M. Depending on the amount of funding needed, we can fund all or a portion of the round, and will work closely with other angel groups or venture funds in the area to complete the round. We are looking for companies that are extremely capital efficient opportunities where our funds will lead to significant step-ups in valuation to avoid unfavorable future funding rounds.